Credit Suisse’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1
| Closed | -$3 | – | 3617 |
|
|
2022
Q4 | $3 | Sell |
1
-16,679
| -100% | -$50K | ﹤0.01% | 3856 |
|
|
2022
Q3 | $617K | Sell |
16,680
-1,242
| -7% | -$45.9K | ﹤0.01% | 2647 |
|
|
2022
Q2 | $340K | Buy |
17,922
+226
| +1% | +$4.29K | ﹤0.01% | 3075 |
|
|
2022
Q1 | $478K | Buy |
17,696
+6,789
| +62% | +$183K | ﹤0.01% | 2994 |
|
|
2021
Q4 | $246K | Buy |
+10,907
| New | +$246K | ﹤0.01% | 3377 |
|
|
2021
Q3 | – | Sell |
-7,223
| Closed | -$231K | – | 3572 |
|
|
2021
Q2 | $231K | Buy |
7,223
+19
| +0.3% | +$608 | ﹤0.01% | 3383 |
|
|
2021
Q1 | $254K | Sell |
7,204
-4,771
| -40% | -$168K | ﹤0.01% | 3206 |
|
|
2020
Q4 | $383K | Buy |
11,975
+6,012
| +101% | +$192K | ﹤0.01% | 3068 |
|
|
2020
Q3 | $224K | Sell |
5,963
-1,984
| -25% | -$74.5K | ﹤0.01% | 3051 |
|
|
2020
Q2 | $355K | Buy |
+7,947
| New | +$355K | ﹤0.01% | 2864 |
|